Literature DB >> 28935733

Complete Genome Sequence of a Genotype 2B Rubella Virus Isolated in South Korea in 2015.

Hae Ji Kang1, You-Jin Kim1, Hye Min Lee1, Jeong-Gu Nam1, Sung Soon Kim2.   

Abstract

The complete genome sequence of the wild-type genotype 2B rubella virus RVi/Busan.KOR/10.15[2B], isolated from a patient in South Korea, was determined. The availability of this sequence will help in understanding the circulation of endemic rubella viruses, as well as their genetic diversity.
Copyright © 2017 Kang et al.

Entities:  

Year:  2017        PMID: 28935733      PMCID: PMC5609412          DOI: 10.1128/genomeA.00940-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Rubella is a highly contagious disease that is commonly considered to be a mild rash illness, but it remains an important global public health problem because it can lead to miscarriage or congenital rubella syndrome in the early stages of pregnancy (1, 2). Effective vaccines and routine immunization programs have reduced the number of rubella cases in many countries (3). In South Korea, the monovalent rubella vaccine was introduced in 1978, and the measles, mumps, and rubella (MMR) vaccine was added to the national immunization program in 1983. A two-dose MMR vaccination schedule was implemented in 1997 (4). Because of such national efforts, the average annual number of rubella cases has been maintained at 30 since 2001, based on data from the national infectious diseases surveillance system operated by the Korea Centers for Disease Control and Prevention (KCDC). Rubella is caused by the rubella virus, which is the only member of the Rubivirus genus in the Togaviridae family. Rubella virus has a single-stranded positive-sense RNA genome with 9,762 nucleotides encoding two nonstructural (P90 and P150) and three structural (one nucleocapsid and two envelope [E1 and E2]) proteins. Phylogenetic analysis based on nucleic acid sequences in the E1 coding region of the virus revealed two distinct groups, clades I and II. Ten genotypes (1a, 1B, 1C, 1D, 1E, 1F, 1G, 1H, 1I, and 1J) have been recognized as belonging to clade I, and three genotypes (2A, 2B, and 2C) have been recognized as belonging to clade II. Genotypes 1E and 2B are frequently detected and show global distribution (5, 6). Despite recent developments in whole-genome sequencing technologies, the number of available complete genome sequences of rubella virus is still less than 50 in GenBank. Among these sequences are only 13 complete genome sequences of genotype 2B isolates (6). Here, we report the full-length genome sequence of a genotype 2B rubella virus isolated from a throat swab specimen of a 36-year-old male in Busan, South Korea, in March 2015 using Vero-hSLAM cells. The cultivated virus was deposited into the National Culture Collection for Pathogens (no. R2017F014), operated by the Korea National Research Institute of Health in South Korea. Total RNA was extracted from the infected Vero-hSLAM cells using the Qiagen RNeasy minikit (Qiagen) and reverse transcribed using SuperScript III first-strand synthesis systems (Invitrogen) with random hexamers. The viral genome was amplified by PCR using gene-specific primers that were designed based on previously published rubella virus sequences. Nucleotide sequences were obtained by direct sequencing using an ABI3730XL DNA analyzer (GnC Bio Co., South Korea). The complete genome of rubella virus strain RVi/Busan.KOR/10.15[2B] contained 9,761 nucleotides, and the virus was phylogenetically classified as genotype 2B. The genome showed 99.2% nucleotide sequence similarity with the complete genome of RVi/HochiMinh.VNM/20.12/Rvv129[2B] (GenBank accession no. AB928203) and 96.3%, 94%, and 97.1% identities with the structural protein gene sequences of the WHO reference strains RVi/Anhui.CHN/00/2[2B] (AY968218), RVi/TelAviv.ISR/68[2B] (AY968219), and RVi/Wash.USA/16.00[2B] (AY968220), respectively.

Accession number(s).

This whole-genome shotgun project for the RVi/Busan.KOR/10.15[2B] isolate has been deposited in GenBank under the accession no. MF496142.
  6 in total

1.  Elimination of rubella and congenital rubella syndrome in the Americas.

Authors:  Carlos Castillo-Solórzano; Christina Marsigli; Pamela Bravo-Alcántara; Brendan Flannery; Cuauhtémoc Ruiz Matus; Gina Tambini; Socorro Gross-Galiano; Jon Kim Andrus
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

2.  An increasing, potentially measles-susceptible population over time after vaccination in Korea.

Authors:  Hae Ji Kang; Young Woo Han; Su Jin Kim; You-Jin Kim; A-Reum Kim; Joo Ae Kim; Hee-Dong Jung; Hye Eun Eom; Ok Park; Sung Soon Kim
Journal:  Vaccine       Date:  2017-06-29       Impact factor: 3.641

Review 3.  Congenital rubella syndrome: a matter of concern.

Authors:  Efrén Martínez-Quintana; Carlos Castillo-Solórzano; Nuria Torner; Fayna Rodríguez-González
Journal:  Rev Panam Salud Publica       Date:  2015-03

Review 4.  Rubella.

Authors:  Nathaniel Lambert; Peter Strebel; Walter Orenstein; Joseph Icenogle; Gregory A Poland
Journal:  Lancet       Date:  2015-01-08       Impact factor: 79.321

5.  Analysis of complete genomes of the rubella virus genotypes 1E and 2B which circulated in China, 2000-2013.

Authors:  Zhen Zhu; Min-Hsin Chen; Emily Abernathy; Joseph Icenogle; Shujie Zhou; Changyin Wang; Chunfang Zhao; Yan Wang; Haiyun Chen; Yuan Si; Wenbo Xu
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379

6.  Genetic diversity of currently circulating rubella viruses: a need to define more precise viral groups.

Authors:  P Rivailler; E Abernathy; J Icenogle
Journal:  J Gen Virol       Date:  2017-04-01       Impact factor: 3.891

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.